Howard Kessler Praises Policy Advances in CBD Access
CBD access policy developments are reshaping patient care and treatment planning. Clinicians must stay informed to provide accurate patient counseling. Understanding regulatory changes is essential for maintaining therapeutic relationships.
Medical Cannabis and Palliative Care: What This End-of-Life Study Actually Shows
This study examines medical cannabis and palliative care utilization among terminally diagnosed patients. It highlights patterns of cannabis use alongside or instead of nonhospice palliative care. The findings offer cautious insights but do not prove…
Cannabidiol for Fibromyalgia: Evidence-Based Cannabis Care
This CBD fibromyalgia clinical trial evaluated the efficacy of cannabidiol in reducing fibromyalgia pain. Results showed no superiority of CBD over placebo. These findings emphasize the need for cautious interpretation of CBD as a treatment option.
Cannabinoids in Children: Clinical Evidence Review
The cannabinoids pediatric safety evidence review covers clinical research spanning 276 studies on cannabinoid use in children. This evolving evidence base reflects growing interest and cautious interpretation due to limited long-term safety data.…
AUNA vs. THC: Which Ambulatory Care Stock Is the Smarter Bet Now? – March 31, 2026
This article provides an ambulatory care stock comparison focusing on AUNA and THC. It highlights the relevance of cannabis healthcare investment trends. Understanding stock performance is crucial for informed investment decisions in 2026.
India’s First Cannabis Research Grant in 50 Years: Fixing the Plan | Ananda Strategy
India cannabis research expansion is underway with the first grant awarded in 50 years. This initiative opens new avenues for clinical studies and policy development. It highlights India's growing role in global cannabis research.
Research, Development, and Innovation Incentives Guide – George Municipality
Municipal cannabis research incentives are a growing trend in local government support for evidence-based cannabis medicine development. George Municipality's guide highlights these incentives as key to advancing clinical research funding. This signals…
CBD Chewing Gum: A Plausible Idea With Very Little Clinical Proof
The CBD chewing gum clinical trial reveals no significant benefit over placebo, underscoring the need for more research. Despite its plausible drug delivery concept, clinical proof remains limited. Understanding the trial outcomes helps guide patient…
This New Therapy Turns Off Pain Without Opioids or Addiction
This article discusses a new non-opioid pain therapy that offers potential addiction-free relief. The focus is on emerging pain management approaches without opioids. Clinical evaluation is pending detailed study data for this non-opioid pain therapy.
New Reasons to Think Twice About Cannabis – Psychology Today
This article highlights cannabis safety clinical evidence that clinicians should consider carefully. Emerging findings require evidence-based data for patient counseling rather than headline-driven concerns. Understanding cannabis safety clinical…